Symbol="GOSS"
AssetType="Common Stock"
Name="Gossamer Bio Inc"
Description="Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapies in the areas of immunology, inflammation, and oncology diseases in the United States. The company is headquartered in San Diego, California."
CIK="1728117"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3013 SCIENCE PARK, SAN DIEGO, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="128850000"
EBITDA="-210287008"
PERatio="None"
PEGRatio="None"
BookValue="-0.298"
DividendPerShare="0"
DividendYield="0"
EPS="-1.91"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.515"
ReturnOnEquityTTM="-259.26"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.91"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="6.15"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="4.091"
EVToRevenue="-"
EVToEBITDA="-0.739"
Beta="1.147"
num_52WeekHigh="15.2"
num_52WeekLow="0.91"
num_50DayMovingAverage="1.347"
num_200DayMovingAverage="3.617"
SharesOutstanding="95444000"
DividendDate="None"
ExDividendDate="None"
symbol="GOSS"
open="1.30"
high="1.43"
low="1.18"
price="1.35"
volume="7990265.00"
latest_trading_day="2023-07-21"
previous_close="1.24"
change="0.11"
change_percent="8.8710%"
aroon_positive_momentum_days="34"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="3037517"
Change_recent_avg="-0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.84"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="1153"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0186.jpeg"
image_negative_thumbnail_id_2="1147"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0180.jpeg"
image_neutral_thumbnail_id_1="545"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0054.jpeg"
image_neutral_thumbnail_id_2="546"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_positive_thumbnail_id_1="979"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0141.jpeg"
image_positive_thumbnail_id_2="965"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0127.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1182"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0016.jpeg"
